Authorised Representative Liability | ProductLiability.help

EU Directive-level explanationUpdated 16 October 2026By ProductLiability.help editorial desk

Start with an actual written appointment

An authorised representative under Article 4 of Directive (EU) 2024/2853 is a natural or legal person established within the Union who has a written mandate from a manufacturer to act on its behalf for specified tasks. A name on packaging, a customer-service address or a generic EU contact does not by itself establish that definition. The manufacturer, appointment and tasks should be identified from evidence.

Article 8(1)(c) includes the manufacturer's authorised representative where the manufacturer of the relevant product or component is established outside the Union. That potential liability is distinct from the representative's everyday compliance tasks. The framework does not require that an importer first disappear or refuse payment before a representative can be considered. The special absence condition in that provision concerns the fulfilment service provider route instead.

Identify the represented manufacturer

Obtain the manufacturer's full legal name, establishment evidence and relationship to the affected product. A brand and a manufacturer are not always the same entity, and a group may appoint representatives for different legal subsidiaries. Record who granted the mandate rather than assuming that a representative appearing on one group website covers every product offered under the shared brand.

Place that relationship within the economic operator framework. A component manufacturer may differ from the finished product manufacturer, with separate representation arrangements. The affected product identifier, software release and relevant market should be linked to the correct appointment. Where the mandate is unavailable, identify the record suggesting the relationship and mark the appointment as unresolved. A plausible appointment should not silently become a confirmed fact in a published account or investigation file.

Check product coverage and dates

A useful mandate record states the parties, covered products or product families, assigned tasks, start date and any termination or replacement. Keep amendments and schedules with the main document. An appointment made after the relevant supply period does not automatically prove who represented the manufacturer earlier. A later website update should not overwrite the historical evidence connecting an earlier representative to the product.

For example, a manufacturer may replace its representative for new models while an earlier company remains named in instructions for an older model. That discrepancy requires examination of the appointments and product scope. It does not prove that both companies are interchangeable. Historical packaging, conformity documents and dated communications can help explain the transition, but their significance should be assessed alongside the mandate rather than used to invent its contents.

Separate liability from compliance tasks

The mandate may concern documentation, regulatory cooperation or other specified activities. Product-safety duties and compensation liability answer different questions. A narrow task description should not be assumed to remove the statutory Article 8 route where its conditions are met. Equally, a representative is not a regulator, certification body or insurer simply because its address appears in regulatory documentation.

The adjacent importer liability route depends on placing a product from a third country on the Union market. A representative can also undertake importing activities, but one role does not automatically establish the other. Record each activity with its own evidence. This distinction helps avoid both omissions and double counting when a single legal entity appears in several parts of the commercial chain.

Keep the underlying claim in view

Establishing a representative's role is only part of the legal analysis. The relevant product must fall within the applicable framework, a safety defect must be considered, covered damage identified and causation examined. The representative's ability to supply documents does not establish whether a component failed or whether an injury resulted from that failure. Technical evidence and actor identification should be developed in parallel.

Article 11 contains exemptions subject to their specific conditions and proof. A party's response to an incident may therefore raise timing, product-supply or manufacturer-control questions requiring further records. Do not reduce the assessment to whether the representative personally designed the product. The Article 8 route deliberately addresses specified market actors beyond the original producer, while the remaining claim conditions continue to matter.

Preserve communications without overstating them

Keep incident notices, manufacturer referrals and replies alongside proof of delivery and the product identifiers used in each communication. A response from a company may confirm it handles enquiries without establishing every aspect of its statutory role. Read the content carefully: an acknowledgement, an admission, a request for information and a denial serve different purposes.

Likewise, silence should not be turned into a conclusion that a representative is necessarily liable. The one-month identification mechanism in Article 8(3) concerns distributors under particular conditions; it is not a universal deadline imposed on every actor receiving an enquiry. National procedure and other applicable duties may require separate consideration. Record the actual legal route before applying a time limit borrowed from another part of the framework.

National implementation and internal arrangements

The corrected Article 2 scope covers products placed on the market or put into service after 8 December 2026. The 9 December 2026 transposition deadline is separate, and national implementing legislation requires review. Record the product date and appointment history rather than assuming that current representation supplies the answer for every older unit or earlier transaction.

Agreements between a representative and manufacturer may allocate costs or provide indemnities, but Article 15 protects the injured person's Directive rights from contractual exclusion or limitation. Internal recovery and the original compensation question should remain distinct. A defensible representative file links the particular product to an identified outside-EU manufacturer, a Union-established appointed entity, the relevant mandate and the applicable period, while clearly stating any unresolved conditions of the claim.

Records that help the review

Use the following as a practical starting point. Select and preserve records appropriate to the product, incident and applicable procedure.

Written mandate, amendments and covered product schedules
Represented manufacturer and Union representative identities
Appointment, replacement and termination dates
Product-specific incident communications and delivery records

Being an authorised representative is not the same as being a regulator, certification body or insurer.

Primary sources and legal scope

This page explains the EU Directive framework. Check national implementing law, the corrected temporal scope and relevant procedure before applying it to a case.

Source register: corrected scope verified 16 October 2026. Article references identify the legal basis. No qualified legal review or national implementation status is claimed.